Hearing Loss Trial, Recruiting (NCT07235488)

Hearing Loss Trial, Recruiting NCT07235488 Sponsor: China Medical University Hospital Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07235488 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older, of any gender.
People who have been diagnosed with sudden sensorineural hearing loss, meaning a hearing loss of more than 30 decibels across at least three connected sound frequencies that developed within 3 days.
People whose hearing loss started within the past 2 weeks.
People who fully understand what the study involves and have signed a consent form agreeing to take part.

Who may not be able to join:

People who have a condition affecting the brain or nervous system, such as a tumour on the hearing nerve or a brain injury caused by trauma.
People who have a problem with the middle ear or with the nerve pathways that carry sound signals beyond the inner ear.
People who have previously had surgery on their ear.
People who have a bleeding disorder or a problem with how their blood clots.
People who, due to dementia or a mental health condition, are unable to cooperate with the examinations required by the study.
People who have already received treatment for sudden hearing loss in the same ear within the past 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-4-22052121 Ext. 14561

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07235488

Sponsor: China Medical University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: +886-4-22052121 Ext. 14561

More information: https://clinicaltrials.gov/study/NCT07235488

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older, of any gender.
People who have been diagnosed with sudden sensorineural hearing loss, meaning a hearing loss of more than 30 decibels across at least three connected sound frequencies that developed within 3 days.
People whose hearing loss started within the past 2 weeks.
People who fully understand what the study involves and have signed a consent form agreeing to take part.

Who may not be able to join:

People who have a condition affecting the brain or nervous system, such as a tumour on the hearing nerve or a brain injury caused by trauma.
People who have a problem with the middle ear or with the nerve pathways that carry sound signals beyond the inner ear.
People who have previously had surgery on their ear.
People who have a bleeding disorder or a problem with how their blood clots.
People who, due to dementia or a mental health condition, are unable to cooperate with the examinations required by the study.
People who have already received treatment for sudden hearing loss in the same ear within the past 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

China Medical University Hospital

Registry

ClinicalTrials.gov

Start date

8 July 2024

Est. completion

20 May 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Pure-tone audiograms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov